Skip to Content

EVR NAT (Everolimus 10 mg)

Pill with imprint EVR NAT is White, Elliptical / Oval and has been identified as Everolimus 10 mg. It is supplied by Breckenridge Pharmaceutical, Inc..

Everolimus is used in the treatment of breast cancer; neuroendocrine carcinoma; pancreatic cancer; organ transplant, rejection prophylaxis; renal angiomyolipoma and belongs to the drug classes mTOR inhibitors, selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Everolimus 10 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for EVR NAT

Everolimus

Imprint
EVR NAT
Strength
10 mg
Color
White
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Mtor inhibitors, Selective immunosuppressants
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Breckenridge Pharmaceutical, Inc.
Manufacturer
Natco Pharma Ltd.
National Drug Code (NDC)
51991-0824

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.